Progress in the Identification of Subgroups in ALK-Negative Anaplastic Large-Cell Lymphoma

References

• Stein H , MasonD, GerdesJet al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood66, 848–858 (1985).
   PubMed Web of Science ®Google Scholar
• Morris SW , KirsteinMN, ValentineMBet al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science263(5151), 1281–1284 (1994).
   PubMed Web of Science ®Google Scholar
• Benharroch D , Meguerian-BedoyanZ, LamantLet al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood91(6), 2076–2084 (1998).
   PubMed Web of Science ®Google Scholar
• Gascoyne RD , AounP, WuDet al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood93(11), 3913–3921 (1999).
   PubMed Web of Science ®Google Scholar
• Swerdlow S , CampoE, HarrisNet al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition). Bosman F , JaffeE, LakhaniS, OhgakiH (Eds). World Health Organization Classification of Tumours, International Agency for Research on Cancer, Lyon, France (2008).
   Google Scholar
• Xing X , FeldmanAL. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv. Anat. Pathol.22(1), 29–49 (2015).
   PubMed Web of Science ®Google Scholar
• Iqbal J , WrightG, WangCet al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood123(19), 2915–2923 (2014).
   PubMed Web of Science ®Google Scholar
• Feldman AL , LawM, RemsteinEDet al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia23(3), 574–580 (2009).
   PubMed Web of Science ®Google Scholar
• Feldman AL , DoganA, SmithDIet al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood117(3), 915–919 (2011).
   PubMed Web of Science ®Google Scholar
• Vasmatzis G , JohnsonSH, KnudsonRAet al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood120(11), 2280–2289 (2012).
   PubMed Web of Science ®Google Scholar
• Parrilla Castellar ER , JaffeES, SaidJWet al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood124(9), 1473–1480 (2014).
   PubMed Web of Science ®Google Scholar
• King RL , DaoL, McphailEet al. Morphology of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Lab. Invest.95, 355A (2015).
   Web of Science ®Google Scholar
• Wada DA , LawME, HsiEDet al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod. Pathol.24(4), 596–605 (2011).
   PubMed Web of Science ®Google Scholar
• Oschlies I , LisfeldJ, LamantLet al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica98(1), 50–56 (2013).
   PubMed Web of Science ®Google Scholar
• Boi M , RinaldiA, KweeIet al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood122(15), 2683–2693 (2013).
   PubMed Web of Science ®Google Scholar
• Crescenzo R , AbateF, LasorsaEet al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell27(4), 516–532 (2015).
   PubMed Web of Science ®Google Scholar
• D’amore F , RelanderT, LauritzsenGFet al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J. Clin. Oncol.30(25), 3093–3099 (2012).
   PubMed Web of Science ®Google Scholar
• Patterson KI , BrummerT, O’BrienPM, DalyRJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J.418(3), 475–489 (2009).
   PubMedGoogle Scholar
• Vilgelm A , El-RifaiW, ZaikaA. Therapeutic prospects for p73 and p63: rising from the shadow of p53. Drug Resist. Updat.11(4–5), 152–163 (2008).
   PubMed Web of Science ®Google Scholar
• Jaffe ES . Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod. Pathol.14(3), 219–228 (2001).
   PubMed Web of Science ®Google Scholar